Manufacturing

New Manufacturing Increasingly Going to Lower Income Towns. This is a Good Thing.

The U.S. manufacturing boom, which started slowly since the implementation of tariffs on steel, aluminum, some China imports, and sped along by new laws favoring domestic supply chains, has had a positive impact on lower income counties nationwide.

Tin Mill

CPA Statement on Closure of Cleveland-Cliffs Tin Mill Facility

The decision, which will result in nearly 1,000 employee layoffs in April, is a direct result of the U.S. International Trade Commission’s (ITC) determination that illegally dumped and subsidized imports of tin mill products from China, Canada and Germany do not sufficiently harm the U.S. domestic steel industry.

China Solar

New Horizon Advisory Report Details Alarming Threat of China’s Stranglehold on Global Solar Market

An alarming new report from Horizon Advisory details China’s distortion of the global solar industry and how that threatens the national and economic security of the United States as it “risks making the United States dependent, and dependent on an adversary, for a strategic, future energy source.”

FDA

House Committee Hearing Discusses FDA’s Shortcomings, Priorities of Supply Over Safety

The expert witness testimony made it clear that U.S. labs were treated differently than foreign ones, and despite increases in hiring at the FDA over the years, lawmakers have a lot to be concerned about when it comes to the FDA conducting proper oversight of foreign manufacturing facilities.

Solar panels

Solar Tariffs Were Supposed to Ruin the Solar Business. They Didn’t, ITC Concludes.

Section 201 solar safeguard tariffs were supposed to ruin the solar business and completely stall deployment of solar on rooftops and vacant fields controlled by electric utility companies. But according to a U.S. government report, they did nothing of the sort.

Ways & Means: Drug Shortages

House Ways & Means Discusses Solutions To Drug Shortages, Foreign Lab Dependence

According to expert testimony given by the witnesses, the crisis is being fueled by poor manufacturing practices that have led to recalls by foreign drug manufacturers, and the race to the bottom on generic drug prices that make it impossible for American generic drug makers to compete with subsidized competitors in India and China.